Background-Ischemic proliferative retinopathy, characterized by pathological retinal neovascularization, is a major cause of blindness in working-age adults and children. Defining the molecular pathways distinguishing pathological neovascularization from normal vessels is critical to controlling these blinding diseases with targeted therapy. 
P athological retinal neovascularization precipitated by vascular loss and hypoxia is the most common cause of blindness in all age groups. Two prominent blinding neovascular eye diseases, retinopathy of prematurity in infants and proliferative diabetic retinopathy in working-age adults, are characterized by abnormal proliferation of pathological vessels. These vessels are distinctly different from normal vasculature morphologically, exhibit increased vascular leakage, and are associated with retinal detachment and blindness. 1, 2 Specifically targeting pathological neovessels while sparing normal vessels would be a major advancement in the treatment of proliferative retinopathy and other vascular diseases with pathological vessel proliferation, such as cancer. Development of such treatment strategies with selective molecular targeting requires a better understanding of the pathways involved in the regulation of pathological retinal blood vessel growth.
Clinical Perspective on p 1881
Wnt signaling may be involved in pathological vessel growth. Mutations in the Wnt pathway cause several hereditary vascular eye disorders, with defective retinal vascular development sharing some characteristics of proliferative retinopathy. [3] [4] [5] [6] [7] [8] [9] The Wnt signaling pathway is fundamentally important in embryonic development and in cancer and cardiovascular diseases. 10 -14 It is essential for cardiac development and differentiation, 15, 16 and is linked to cardiac hypertrophy, cardiac failure, and vascular aging. 17, 18 However, the contribution of Wnt to pathological angiogenesis has not been determined.
Canonical Wnt pathway signaling starts with the binding of a Wnt ligand to the Wnt receptor Frizzled (Fzd) and recruitment of coreceptor low-density lipoprotein receptor-related protein (Lrp5/6), activating and stabilizing ␤-catenin. 14 After translocation to the nucleus, ␤-catenin binds the transcription factor Lef/TCF and activates target gene transcription. 10, 14 Canonical Wnt signaling is implicated in neuronal development, 19 cancer, 20, 21 regression of embryonic hyaloid vessels in the eye, 22 and blood-brain barrier formation. [23] [24] [25] Mutations in the Wnt receptors Fzd4 and Lrp5 and in the Wnt ligand Norrin are linked to hereditary vascular eye diseases in human and in mouse models. 26 -29 Mice deficient in the Wnt coreceptor Lrp5 have persistent embryonic hyaloid vessels in the eye 9, 28 (and low bone density), recapitulating human autosomal-recessive osteoporosis-pseudoglioma syndrome, a form of familial exudative vitreoretinopathy. Depletion or mutations in Lrp5 result in lack of deeper retinal vessels, 30, 31 similar to mice lacking Wnt receptor Fzd4 or Wnt ligand Norrin. 26, 27, 29 However, the potential role of Wnt signaling in pathological neovascularization during other postnatally occurring retinal vascular diseases, such as retinopathy of prematurity and diabetic proliferative retinopathy, is not defined, and is the focus of this study.
Using a mouse model of oxygen-induced proliferative retinopathy (OIR), 32 we investigated the contribution of the Wnt signaling pathway in pathological vascular growth in retinopathy. We found that components of Wnt signaling are significantly upregulated in pathological neovessels with induced retinopathy. Loss of Lrp5 and Wnt signaling protein dishevelled2 (Dvl2) results in significantly decreased levels of pathological neovascularization in retinopathy. In addition, loss of Lrp5 results in abnormal vascular growing tips and breakdown of the blood-retina barrier, which is linked to downregulation of the tight junction protein claudin5 (Cln5) in retinal vessels. Importantly, inhibition of Cln5 suppresses endothelial sprouting in vitro and retinal vascular growth in vivo both during development and in retinopathy. These results indicate a crucial role of Wnt signaling in promoting pathological retinal neovascularization in retinopathy beyond its known role in developmental retinal angiogenesis, suggesting that specific targeting of this pathway may lead to treatment options for proliferative retinopathy.
Methods

Retinal Vascular Phenotype Analysis and OIR
Retinal dissection vascular staining and image analysis were performed using standard published protocols. 33, 34 To induce pathological neovascularization in retina, mice with their nursing mother were exposed to 75% oxygen from postnatal day (P) 7 to P12, followed by room air. 32 At P17, when the neovascular response is greatest, pathological retinal neovascularization was evaluated. To examine the level of gene transcripts, cDNA was prepared from isolated retina at various ages, followed by quantitative reversetranscription polymerase chain reaction analysis.
Endothelial Cell Spheroid Sprouting Assay
Human retinal microvascular endothelial cells were cultured and prepared for spheroids as described previously. 35, 36 Sprouting was photographed after treatment of Wnt3a, Wnt7a, vascular endothelial growth factor (VEGF), and Cln5 antibodies for 24 hours, and images were assessed with results expressed as meanϮSEM (n is the number of spheroids quantified).
Intravitreal Injection
Intravitreal injections with Cln5 antibody or Cln5 small interference RNA (siRNA) were performed at specific ages following published protocols. 37 Retinas were isolated for RNA analysis or flat mounted for analysis of vascular phenotype during development and in OIR.
Laser-Capture Microdissection of Retinal Vessels
Retinal vessels were microdissected with laser capture in retinal cross sections from P8 Lrp5 Ϫ/Ϫ and wild-type mice, as described previously. 37, 38 Enrichment of endothelial cells was confirmed. RNA was extracted and cDNA synthesized for quantitative reversetranscription polymerase chain reaction analysis.
Statistics
Results are presented as meanϮSEM for animal studies and meanϮSD for nonanimal studies. For all statistical analysis, the F test (for 2 samples; for Ͼ2 samples, the Levene test) was performed first to assess whether the variances were homogeneous. If the variances were homogeneous, a 2-sample t test (or ANOVA for Ͼ2 groups of samples) assuming equal variance was performed. If not, a 2-sample t test (or ANOVA) assuming unequal variance was performed.
Results
Delayed and Incomplete Retinal Vasculature of
To study the role of Wnt coreceptor Lrp5 in retinal angiogenesis, we first characterized vascular development of the retina in the Lrp5 Ϫ/Ϫ mouse. Murine retinal vascular development starts at birth. The superficial vascular plexus grows radially from the optic disc, reaching the periphery by P8. The development of the deeper secondary and tertiary network of capillaries follows, and is complete Ϸ3 weeks after birth. 39 This stereotyped development is perturbed in adult Lrp5 Ϫ/Ϫ retinas, where vessels are large, dilated, and tortuous, with abnormal aggregations of endothelial cells in the midperiphery of the primary vascular plexus ( Figure 1A ). Although Lrp5 Ϫ/Ϫ retinas still display vertical vessels extending from the primary vessel plexus toward the deeper vascular layers, these vertical vessel sprouts terminate without forming interconnections, thus failing to create the 2 deeper layers of capillary networks in the inner and outer plexiform layers ( Figure 1B and 1C) . Additionally, glial fibrillary acidic protein levels are increased in astrocytes and Muller cells of Lrp5 Ϫ/Ϫ eyes, indicating increased retinal stress associated with defective retinal vasculature ( Figure 1C ). The retinal vasculature of heterozygous Lrp5 ϩ/Ϫ mice appears normal ( Figure 1A through 1C) .
In addition to analyzing the mature retinal phenotype in adult retinas, we assessed retinal vascular development in Lrp5 Ϫ/Ϫ retinas compared with the phenotypically normal Lrp5 ϩ/Ϫ mice ( Figure 1D ). At P5, the area of vascularized retina is Ϸ25% less in Lrp5 Ϫ/Ϫ mice compared with heterozygous littermate controls (27Ϯ1.9% versus 36Ϯ1.3% of total retinal area; PՅ0.001; Figure 1D and 1E). At the leading edge of the developing vasculature in Lrp5 Ϫ/Ϫ retinas, the vessels appear thickened and the number of vascular sprouting tips is significantly reduced (by Ϸ30%) compared with littermate controls (12.6Ϯ1.1 versus 18.1Ϯ1.4 sprouts per view field; PՅ0.001; Figure 1D and 1E). At P8, when the superficial layer of control retinas is almost 100% vascularized, Lrp5 Ϫ/Ϫ retinas are only 70% vascularized. These results suggest that loss of the Wnt coreceptor Lrp5 directly contributes to delayed retinal vessel development.
Localization and Expression of Lrp5 in Neovessels in Developing Retina
We next localized Lrp5 protein in the retina to the developing primary vessel plexus (at P6) ( Figure 1F ). At P13 and P17, when deeper layers of retinal vessels are forming and the superficial vascular layer is complete, Lrp5 staining shifts predominantly to these newly developing vascular layers ( Figure 1F ), indicating that Lrp5 is expressed preferentially in newly formed vessels compared with mature blood vessels. This notion is supported by the robust expression of Lrp5 mRNA in whole retina during the first week after birth, when rapid vascular growth occurs in the primary vascular plexus. 
Localization and Expression Patterns of Wnt Receptors and Activity in Pathological Retinal Neovessels
Having established the importance of Wnt signaling and Lrp5 in normal retinal vessel development, we next asked whether the Wnt pathway contributes to the formation of pathological retinal neovascularization in OIR. 32 In OIR, mouse pups are exposed to 75% oxygen from P7 to P12, followed by room air with a maximum neovascular response at P17 (Figure 2A) . We assessed the effects on the pathological neovascular response of modulating the Wnt pathway (ligands and receptors, as well as the downstream signaling protein Dvl and ␤-catenin stabilization; Figure 2B ).
During OIR, the Wnt receptor Fzd4 is found specifically in pathological neovascular tufts ( Figure 2C ). Wnt activity was localized with the Wnt reporter TOP-Gal mice, which express the lacZ gene under the control of Tcf promoters and hence synthesize lacZ only in cells with active canonical Wnt/␤-catenin signaling. 40, 41 Similar to Fzd4, activated Wnt signaling, as evidenced by anti-lacZ staining, is observed specifi- cally in neovascular tufts in OIR retinas ( Figure 2C ). Moreover, we also localized the Wnt ligand Norrin to a subset of macrophages associated with retinal vessels as seen by colocalization with CSF1-R ( Figure 2C ). Because in situ hybridization is not quantitative, we used laser-capture microdissection to isolate pathological neovascularization tufts from OIR mice and normal vessels from control mice to measure specific mRNA expression of Wnt receptors in retinal vasculature. Wnt receptor Fzd4 and Lrp5 mRNA levels are Ϸ3-to 5-fold higher in neovessels compared with normal vessels ( Figure 2D ).
Mice Lacking Wnt Signaling Show Decreased Levels of Pathological Neovascularization in Retinopathy
To assess whether Wnt signaling contributes to the formation of pathological neovascularization, retinopathy (OIR) was induced in Lrp5 Ϫ/Ϫ mice. With loss of Lrp5, there was significantly less pathological neovascularization compared with wild-type controls (5.9Ϯ0.3% versus 8.3Ϯ0.6% of total retina area; PՅ0.001; Figure 3A Figure 2B ). We found normal retinal vascular development in Dvl2 Ϫ/Ϫ mice ( Figure IIA and IIB in the online-only Data Supplement), potentially reflecting redundant roles of Dvl1, Dvl2, and Dvl3 in development. 43 However, with OIR, Dvl2 Ϫ/Ϫ retinas develop significantly less pathological neovascularization than littermate controls (6.5Ϯ1% versus 9.1Ϯ0.5%; PՅ0.01; Figure 3B ). These results suggest that Wnt signaling through Lrp5 and Dvl2 is important for the formation of pathological neovascularization in the OIR model independently of abnormalities in normal retinal development, and that blocking the Wnt pathway by genetic depletion of either Lrp5 or Dvl2 suppresses pathological neovascularization formation.
Increased Expression of Wnt Ligands in Retinopathy
Having established that loss of Wnt signaling affects pathological neovascularization in retinopathy, we next asked which Wnt ligands are regulated during pathological neovas- cularization. Wnt3a, Wnt7a, and Wnt10a mRNA expression is significantly upregulated in OIR retinas at P17 compared with room-air controls, with Wnt7a and Wnt10a mRNA increasing up to 7-to 10-fold ( Figure 3C) . Expression of the Wnt ligand Norrin is not significantly altered during OIR ( Figure 3C ). These data suggest that Wnt3a, Wnt7a, and Wnt10a are likely Wnt ligands contributing to pathological neovessel formation in the OIR retina.
Downregulation of Cln5 and Disruption of Blood-Retina Barrier in Lrp5
؊/؊ Retina
To unravel the molecular mechanisms by which Wnt signaling regulates retinal angiogenesis, we analyzed mRNA expression in wild-type and Lrp5 Ϫ/Ϫ retinas at P8 with a microarray. With loss of Lrp5 we identified a significant Ϸ8-fold reduction in expression of the tight junction protein Cln5, confirmed by quantitative reverse-transcription polymerase chain reaction ( Figure 4A ). Protein levels of Cln5 are also markedly reduced in Lrp5 Ϫ/Ϫ retinas ( Figure 4B ). Cln5 protein is localized predominantly by immunohistochemistry to retinal vessels in both wild-type and Lrp5 Ϫ/Ϫ retina (with lower staining intensity in Lrp5 Ϫ/Ϫ vessels; Figure 4C ). Because immunohistochemistry is not quantitative, we used laser-capture microdissection to isolate retinal vessels from Lrp5 Ϫ/Ϫ and wild-type mice, followed by reverse-transcription polymerase chain reaction to analyze gene expression specifically in vessels. We confirmed that Cln5 mRNA is significantly decreased in retinal vessels of Lrp5 Ϫ/Ϫ mice, whereas Plvap, a marker of vascular permeability, is increased compared with vessels isolated from wild-type retinas ( Figure  4D) . Expression of the endothelial cell marker VE-Cadherin is the same (Figure 4D ). The transcription factors Sox17 and Sox18 are also significantly downregulated in Lrp5 Ϫ/Ϫ vessels compared with wild-type vessels by Ϸ2-and 4-fold, respectively ( Figure 4D ). The observation that Sox17 mRNA expression is decreased in Lrp5 Ϫ/Ϫ vessels is in agreement with a previous study reporting decreased Sox17 transcripts in Wnt receptor Fzd4 Ϫ/Ϫ endothelial cells. 44 The finding that Sox18 is regulated by Wnt signaling, however, was not reported previously. Because Sox18 is known to control expression of Cln5, 45 we assessed expression of Sox18 and Cln5 in human retinal microvascular endothelial cells treated with siRNA targeting Lrp5 and Sox18. Compared with control siRNA, Lrp5 siRNA significantly inhibited Lrp5 expression by Ͼ3 fold ( Figure 4E ). Lrp5 siRNA treatment significantly inhibited mRNA expression of both Sox18 and Ϫ/Ϫ mice exposed to OIR compared with wild-type controls. Areas of pathological neovascularization are quantified as percentage of total retinal area. nϭ16 to 29 per group; ***PՅ0.001. B, Quantification of pathological neovascularization in P17 retinas from Dishevelled2 Ϫ/Ϫ (Dvl2) mice exposed to OIR compared with heterozygous littermate controls. nϭ8 to 24 per group; **PՅ0.01. C, mRNA expression of Wnt ligands Wnt3a, Wnt7a, Wnt10a, and Norrin in P17 wild-type retinas exposed to OIR compared with age-matched mice raised in room air. Scale bars: A and B, 1000 m.
Cln5. Sox18 siRNA treatment successfully inhibited Sox18 expression and, importantly, inhibited Cln5 mRNA expression by Ͼ3 fold ( Figure 4E ). Together, these in vitro data show that the transcription factor Sox18 mediates downregulation of Cln5 in Lrp5-deficient endothelial cells.
Because Cln5 is a known tight junction protein essential for maintaining vessel integrity 46, 47 and Plvap is an indicator of vessel permeability, 48, 49 we assessed the blood-retinal barrier function in Lrp5 Ϫ/Ϫ mice and found increased bloodretinal barrier permeability when subjected to fluorescent Ϫ/Ϫ and WT retinas examined with FITC-dextran perfusion (green) or (G) by staining for mouse IgG (green), which is normally confined within blood vessels. Scale bars: C and F, 50 m; G, 100 m. *PՅ0.05, **PՅ0.01, ***PՅ0.001.
angiography with FITC-dextran ( Figure 4F ). In a complementary assay, mouse plasma IgG, which normally is confined to vessels in wild-type mice with intact blood-retinal barrier, extravasates into the neuronal tissue of the retina in Lrp5 Ϫ/Ϫ mice, also indicating blood-retinal barrier breakdown ( Figure 4G ). Together, these results suggest that the vasculature of Lrp5 Ϫ/Ϫ retinas is more permeable than that of wild-type retinas.
Blocking Cln5 Suppresses Wnt-Stimulated Endothelial Spheroid Sprouting In Vitro and Developmental Retinal Angiogenesis In Vivo
To further investigate the molecular mechanisms that cause impaired angiogenesis in Lrp5 Ϫ/Ϫ mice, we examined VEGF in Lrp5 Ϫ/Ϫ retinas. Lrp5 Ϫ/Ϫ retinas display similar levels of VEGF mRNA expression at P5 and P8 during vascular development of the superficial vascular layer. After the initial vascular growth, there is a breakdown of vascular development after P8, likely leading to inadequate perfusion of the developing retina. Without normal vascular development, there is a significantly increased level of VEGF at P12 and P17 compared with wild-type controls ( Figure 5A ). This observation suggests that the delay and lack of vascular growth in Lrp5 Ϫ/Ϫ mice are not caused by VEGF deficiency. Other pathways that are critical for angiogenesis, such as the angiopoietin-Tie2 pathway 50 -52 and Notch pathway 53, 54 are also not significantly affected in Lrp5 Figure 5D ). In addition, to assess the effect of Cln5 on deep vessel layer formation, we injected Cln5 antibody intravitreally at P4 and found that inhibition of Cln5 at P9 also significantly suppresses retinal vascular growth in the deep retinal layer compared with control IgG (deep retinal area without vessels, 88.1Ϯ1.8% versus 66.0Ϯ7.9% of total retina area; PՅ0.01; Figure 5E ). 
Inhibition of Cln5 With siRNA Suppresses Pathological Retinal Neovascularization in Retinopathy
To corroborate these in vivo results obtained with Cln5 antibodies, we assessed the effect of Cln5 on vascular growth in vivo with siRNA targeting Cln5. The specificity and effectiveness of the Cln5 siRNA were previously validated. 55 We confirmed that intravitreal injection of Cln5 siRNA significantly suppresses retinal Cln5 mRNA expression by Ͼ3-fold ( Figure 6A ) and in development significantly inhibits retinal vascular growth compared with contralateral eyes injected with control siRNA (avascular area, 12.8Ϯ1.1% versus 8.2Ϯ1.0% of total retinal area; PՅ0.01; Figure 6B ). To assess whether suppression of Cln5 also suppresses pathological retinal neovessels, we injected intravitreally Cln5 siRNA in OIR mice at P14. At P17, Cln5 siRNAinjected eyes had significantly less pathological neovascularization (9.2Ϯ0.7% of total retinal area) compared with contralateral eyes injected with control siRNA (11.4Ϯ0.7% of total retinal area; PՅ0.01; Figure 6C ). Together, these data suggest that inhibition of Cln5 significantly suppresses angiogenesis both in vitro and in vivo, indicating a novel function of Cln5 in promoting angiogenesis not only during development but also during pathological neovessel formation.
Discussion
In this study, we present novel evidence showing that the Wnt pathway signaling is important for formation of pathological neovascularization in retinopathy. It is important to distinguish biochemical pathways differentially involved in pathological neovascularization to consider specific control of pathological angiogenesis (characterized by abnormal proliferation and increased vascular leakage) versus normal mature vessels. Mutations in the Wnt ligand Norrin and receptors Fzd4 and Lrp5 have previously been linked to several rare human eye diseases such as Norrie disease 26 and familial exudative vitreoretinopathy, 5, 8 both of which have features of abnormal retinal vessel development and vascular leakage. Recent studies have identified a new binding protein of the Wnt receptor tetraspannin (TSPAN12), which enhances Wnt signaling, 56 and transcription factor Sox17, which is upregulated by Wnt signaling. 44 However, the role of Wnt signaling in pathological proliferative neovascularization remained undefined.
Here, we find that Wnt receptors and activity are selectively upregulated in pathological neovessels in the retina in a mouse model of OIR. Reduction of Wnt signaling in Lrp5 Ϫ/Ϫ mice or Dvl2 Ϫ/Ϫ mice significantly suppresses pathological neovessel formation in OIR. These results are in line with a previous study showing that ectopic expression of Wnt ligand Norrin promotes vascular regrowth in OIR. 57 Together, these findings suggest that modulation of Wnt signaling has significant implications not only for congenital hereditary eye diseases with mutations in Wnt pathway but also for the much more prevalent postnatally occurring retinal vascular diseases like diabetic retinopathy, retinopathy of prematurity, and macular degeneration, all of which are characterized by pathological vascular growth. Interestingly, in this context, retinopathy of prematurity in some severe cases has been linked to mutations of the Wnt ligand Norrin, 58 and age-related macular degeneration has been associated with gene polymorphisms in the Wnt coreceptor Lrp6. 59 In addition to defining the role of Wnt signaling in proliferative retinopathy, in this article, we expanded the characterization of Lrp5 in developmental retinal angiogenesis. Decreased numbers of retinal vascular sprouts and an incomplete deep layer of blood vessels in Lrp5 Ϫ/Ϫ retinas are similar to the retinal vascular development abnormalities seen in Norrin Ϫ/Ϫ and Fzd4 Ϫ/Ϫ mice. 26, 27, 30, 44 Fzd4 expression is the same in Lrp5 Ϫ/Ϫ retina compared with wild-type retina; however, a few other Fzd receptors (Fzd2, Fzd3, Fzd7) are downregulated, reflecting potential compensatory regulation ( Figure V in the online-only Data Supplement). Lrp5 protein is expressed preferentially in newly formed versus mature retinal vessels during development and in pathological neovessels during OIR. Although expression in other retinal cell types, such as neurons and Muller glia cells, cannot be excluded, 31 it is likely that the vascular Wnt receptors Fzd4 and Lrp5 are direct regulators of vascular growth in retinopathy, consistent with a previous report showing that conditional loss of Fzd4 in vascular endothelial cells results in retinal vascular defects similar to systemic Fzd4-null mice. 44 Our study identifies the tight junction protein Cln5 as a direct mediator of retinal angiogenesis regulated by Lrp5 Figure 6 . Claudin5 (Cln5) siRNA suppresses developmental retinal angiogenesis and formation of pathological neovascularization in oxygen-induced retinopathy (OIR). A, Cln5 siRNA significantly suppresses retinal expression of Cln5. Mice were injected intravitreally with Cln5 siRNA in 1 eye and control negative siRNA in the other eye at P4. Retinas were isolated at P6, and Cln5 mRNA expression was quantified with quantitative reverse-transcription polymerase chain reaction. nϭ3. *PՅ0.05. B, Quantification of P7 retinal vascular growth during development with Cln5 siRNA injected intravitreally at P4 and control siRNA injected in the contralateral eye. nϭ10. **PՅ0.01. C, Quantification of P17 OIR retina with Cln5 siRNA and control siRNA injected intravitreally at P14 after mice were exposed to 75% oxygen from P7 to P12 to induce retinopathy. nϭ14. **PՅ0.01.
through the transcription factor Sox18. Cln5 is a key component of endothelial cell tight junctions essential in maintaining cell-cell adhesion. Blocking Cln5 significantly suppresses retinal blood vessel during development in both superficial and deep retinal layers and suppresses pathological neovessel formation in proliferative retinopathy in mice. This effect is corroborated in vitro in that blocking Cln5 significantly suppresses Wnt-dependent endothelial cell spheroid sprouting. It has been shown previously that blocking a different adhesive protein, R-cadherin, inhibits retinal angiogenesis. 60 Inhibition of the endothelial cell adhesion protein VEcadherin also suppresses neovessel sprouting and angiogenesis. [61] [62] [63] [64] Similarly, Cln5 may be necessary for cell-cell adhesion, endothelial cell migration, and tube formation, and thus would play an essential role in the proper growth of vascular sprouts and vessel growth. It is likely that Cln5 is finely regulated in the retina for optimal tight junction function. Downregulation of Cln5 may contribute, at least in part, to the delayed formation of the primary plexus and to the complete lack of deeper capillaries in Lrp5 Ϫ/Ϫ retinas. It is important to note that Cln5 is also suppressed in Norrin Ϫ/Ϫ retinas (seen in a gene expression microarray study 65 ), suggesting that Cln5 may mediate common effects of Wnt signaling in vascular growth.
This previously undiscovered function of Cln5 in retinal angiogenesis is in addition to its known role in blood-brain (or blood-retinal) barrier formation. Both familial exudative vitreoretinopathy and retinopathy of prematurity are characterized by not only inadequate retinal vascularization, but also peripheral retinal vascular leakage, 2,3 which might be attributable in part to a lack of Cln5. In line with our observations that loss of Wnt signaling in Lrp5 Ϫ/Ϫ retinas results in decreased blood-retinal barrier integrity, loss of Wnt ligands Wnt7a and Wnt7b is associated with disruption of tight junctions and loss of blood-brain barrier properties in the central nervous system. [23] [24] [25] In the brain, deficiency of Cln5 has been linked to blood-brain barrier breakdown, 47 and Cln5-null mice die soon after birth as a result of defective blood-brain barrier formation. 46 Similarly, in line with our findings that Cln5 is a downstream target of Lrp5 via Sox18, Cln5 has been found to be downregulated in vascular endothelial cells in the absence of ␤-catenin. 24, 53 Together, these results support the concept that canonical Wnt signaling through Lrp5, ␤-catenin, and Sox18 regulates Cln5 expression in endothelial cells, which in turn mediates not only endothelial barrier function in the retina, but also retinal blood vessel growth in development and in pathology.
Conclusions
This article provides direct evidence for an important role of Wnt signaling mediating pathological neovascularization. Given the selectivity of Wnt signaling for proliferating vessels, the therapeutic implications for modulating components of Wnt/␤-catenin pathways in pathological vessel proliferation are broad. Our identification of the Wntdependent angiogenic effects of Cln5 further adds to the potential therapeutic spectrum of Wnt modulation in angioproliferative diseases. In this respect, modulation of canonical Wnt pathways could be potentially advantageous for treating not only retinopathy, but also other diseases such as tumors in which pathological angiogenesis and loss of vascular integrity play a significant role. 
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